LifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at HC Wainwright
LifeMD (NASDAQ:LFMD – Get Free Report) had its target price lifted by HC Wainwright from $12.00 to $14.00 in a research report issued on Wednesday, MarketBeat reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 147.35% from the stock’s current price. A number of […]
LifeMD (NASDAQ:LFMD – Get Free Report) had its target price lifted by HC Wainwright from $12.00 to $14.00 in a research report issued on Wednesday, MarketBeat reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 147.35% from the stock’s current price. A number of […]
